
We’ve Been in Your Shoes. Now We’re at Your Side.
Our heritage dates back to 2009, working with an early stage company on a therapy for protein misfolding. Since then, we have had different names, expanded our services, and now created ElevEx BioGroup with a new focus on tackling today's business and regulatory challenges on the way to commercialization.
You’re engaging a team of seasoned life science professionals who bring insight, accountability, and deep industry experience from day one.
Who Are We?
The experts you meet are the ones who stay with you—driving the work, solving the problems, and delivering the outcomes.
Our Heritage
Our experts brings more than a century of collective experience across large and mid-sized biopharma, global markets, emerging biotech, and digital therapeutics. We’ve launched products, led transformations, adapted to complexity, and delivered real change from within. That perspective shapes everything we do—pragmatic, strategic, and always focused on moving your business forward in deliberate, measurable steps.
Meaningful Expertise






Behind our Name and Logo
Rooted in symbolism; we crated ElevEx BioGroup with a purpose:
Elev + Ex = Elevate + Expertise / Excellence / Expansion
Bio + Group = Biological Sciences + Team-Oriented Approach
Our DNA Helix represents our commitment as Experts (X) to life science, with four horizontal strands representing each of our founders.

Introductions

With over 20 years of experience in pharmaceuticals and medical devices, I specialize in market access strategy, payer engagement, and commercial launch planning. My background spans leading national teams, advising start-ups, and navigating complex reimbursement landscapes across retail, specialty, and digital therapeutics. Rooted in 15 years of clinical and administrative work in behavioral health, I bring a patient-centered, pragmatic approach to commercialization.
Paul Bragoli

Alvin Mok
I build agile, fit-for-purpose Commercial Operations for biotechs of all sizes—drawing on experience across oncology, specialty therapeutics, and digital health. With roots in global M&A and a career spanning analytics, launch strategy, and team transformation, I bring a rare blend of rigor and curiosity to every challenge. My approach is practical, scalable, and always tailored to the science, culture, and complexity at hand.



Bryan Quinn
I turn complex data into clear, actionable insights that drive commercial impact. With experience across healthcare, biotech, and pharma—and an MBA to ground my work in business strategy—I design analytics that are intuitive, collaborative, and built for real-world decision-making. Whether supporting sales, market access, or ops teams, I focus on what matters most: helping people make smarter, faster decisions that move the needle.


Coming Soon



Chris Seagle; PhD, MBA
I lead market access, pricing, HEOR, and portfolio strategy to unlock product value and expand patient access across biopharma. With experience spanning global pharma and nimble biotech, I bring a multidisciplinary lens—rooted in science, strategy, and collaboration—to drive impactful, scalable solutions across oncology, rare diseases, immunology, and more. I see market access not as a function, but a mindset that transforms how companies deliver innovation.


